Nav: Home

Bariatric surgery may not lead to lower health care costs

October 30, 2019

Despite health benefits of improved survival and significant weight loss, bariatric surgery may not lead to lower health care costs, according to a Veterans Affairs study. The 10-year study is the longest follow-up to date of long-term health care costs after bariatric surgery in the United States.

The study appears Oct. 30, 2019, in JAMA Surgery.

Obesity contributes to a number of health problems, such as diabetes and heart disease. When other treatments prove ineffective at weight loss, patients with severe obesity may be offered bariatric surgery.

Bariatric surgery achieves weight loss by restricting how much food the stomach can hold, by limiting how much food can be absorbed, or both. It includes several different procedures, such as gastric bypass, sleeve gastrectomy, and gastric banding.

Surgery can lead to significant and sustained weight loss, better survival, and better health. However, the surgery itself and management of post-surgical complications can be costly.

To address whether the health benefits of bariatric surgery lead to lower costs, the study team--led by Dr. Matthew Maciejewski of the Durham VA Medical Center and Duke University--compared more than 10 years of data on VA patients who had bariatric surgery with similar VA patients who did not. The study included nearly 10,000 veterans with severe obesity, almost 2,500 of whom had bariatric surgery.

The results showed that patients who had bariatric surgery did not have lower VA health care costs in the 10 years after surgery. This finding was consistent with prior studies on non-veterans and prior research by the same team on veterans that compared costs three years after surgery.

The surgery group had higher VA costs in the 6 to 12 months before and in the first two years after surgery. Total health care costs were $1,400 higher for the surgery group than the non-surgery group at 12 months before surgery. In the six months after surgery, surgery patients had total VA costs that were $3,000 higher than their non-surgery peers.

Health care costs for surgery patients gradually decreased two years after surgery. By 5 to 10 years after surgery, they had similar total costs to matched non-surgery patients. The surgery patients had lower average pharmacy costs than the non-surgery group over the 10-year period, but this was offset by higher outpatient expenses. VA costs for surgical patients never dropped below those of the non-surgery patients.

Although it was not the focus of this study, the researchers proposed several reasons that may explain why the surgery group did not have lower costs years after their procedures. Despite better overall health, patients may still need to be treated for short-term complications of bariatric surgery. Surgery patients likely had higher inpatient costs in the months following bariatric surgery to treat surgical complications such as nausea, vomiting, and dehydration. They may also experience anemia and vitamin deficiencies that require management by VA providers.

Further, patients may have had higher costs from having additional procedures, such as for the removal of excess skin. Patients who lost weight also may have become newly eligible for hip or knee replacement surgeries for osteoarthritis. Finally, many conditions linked to obesity, such as diabetes, do not always go away once a patient loses weight and may require routine monitoring and follow-up.

Overall, the results suggest that the primary benefit from bariatric surgery is in health and quality-of-life improvements, not cost-savings. Maciejewski and coauthor Dr. David Arterburn noted in an email that "few health care treatments are required to be cost-saving or even cost-effective to be widely available, so requiring cost-savings of bariatric surgery imposes an unfair standard." They acknowledge that increasing access to bariatric surgery would obviously entail greater health-system costs.

Future research should focus on whether newer bariatric surgery procedures are able to reduce health care costs more than older procedures, say the researchers. For example, sleeve gastrectomy is less invasive than gastric bypass, but was performed on only 15% of the surgical patients in the study, given that it is a newer procedure. Sleeve gastrectomy could potentially be more cost-effective because of lower up-front costs and risks of complications, but further research is needed to explore this possibility.
-end-
The study was funded by VA Health Services Research and Development and the National Institute on Drug Abuse. To learn more about VA research into obesity, visit http://www.research.va.gov/topics/obesity.cfm.

Veterans Affairs Research Communications

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Accessing Better Health
Essential health care is a right, not a privilege ... or is it? This hour, TED speakers explore how we can give everyone access to a healthier way of life, despite who you are or where you live. Guests include physician Raj Panjabi, former NYC health commissioner Mary Bassett, researcher Michael Hendryx, and neuroscientist Rachel Wurzman.
Now Playing: Science for the People

#544 Prosperity Without Growth
The societies we live in are organised around growth, objects, and driving forward a constantly expanding economy as benchmarks of success and prosperity. But this growing consumption at all costs is at odds with our understanding of what our planet can support. How do we lower the environmental impact of economic activity? How do we redefine success and prosperity separate from GDP, which politicians and governments have focused on for decades? We speak with ecological economist Tim Jackson, Professor of Sustainable Development at the University of Surrey, Director of the Centre for the Understanding of Sustainable Propserity, and author of...
Now Playing: Radiolab

An Announcement from Radiolab